Last accessed: January 2025
Best Practices for Safe Use of Brello Health GLP-1 Telehealth Weight Loss Medical Evaluation Required All Brello Health patients undergo a thorough medical intake and telehealth consultation before being prescribed GLP-1 medications
Evidence: Retained Gastric Contents Versus Aspiration Events The evidence should be divided into three categories: mechanistic evidence, retained-gastric-content evidence, and clinical outcome evidence
Take home message Eli Lilly reported on 21 May 2026 that retatrutide produced an average weight loss of up to 30.3% in its Phase 3 TRIUMPH-1 trial, the largest figure reported so far for a weight-loss injection
By boosting glutathione levels, NAC helps neutralize free radicals, reduce oxidative stress, and support liver detoxification processes
From gut microbiota through low-grade inflammation to obesity: key players and potential targets